Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- A Phase 3..Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously......
- A Phase 3..Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously......
- A Phase 3: Open-Label Study of the Safety of Hpn-100 for Thelong Term Treatment of Urea Cycle Disorders (Treat Ucd).....
- A Phase 3B Continuation Study of the Safety and Efficacy of Pegylated Recombinant Factor Viii (Peg-Rfviii; Bax 855)
- A Phase 3b Study of 2 Treatment Durations of Telaprevir, Peg-IFN (Pegasys®), and Ribavirin (Copegus®) in Treatment-Naïve and Prior Relapser Subjects with Genotype 1 Chronic Hepatitis
- A Phase 3B, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic ....
- A Phase 3b, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Subjects with Primary Biliary Cirrhosis
- A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir / Pibrentasvir +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C Previously Treated with an NS5A Inhibitor + Sofosbuvir Therapy
- A Phase 3b, Multicenter Double-Blinded Placebo-Controlled Parallel Study of Alv
- A Phase 3b, Randomized, Open-Label, Active-Controlled Study to Compare the Effects of Tarka and Lotrel On
- A Phase 4 Randomized Open-Label Active-Controlled Study to Compare the Effects Od Tarka and Lotrel on Albuminuria.....
- A Phase 4 Study to Evaluate the Effect of Weekly Augmentatiotherapy With Aralast Fraction IV-1 (Fr IV-1) Alpha1-Pro.....
- A Phase 4, Open-Label, Prospective Study in Patients With Pompe Disease to Evaluate the Efficacy & Safety of Algluc...
- A Phase 4, Prospective, Multinational, Open-Label, Noninferiority Study of Aglucosidase Alfa Manufactured At...
- A Phase I Clinical Trial of Oxi4503 for Relapsed and Refractory Acute Myelogenous Leukemia (Aml)and Mds
- A Phase I Dose Finding Study of Panobinostat in Children With Refractory Hematologic Malignancies
- A Phase I Study to Evaluate the Safety of Wingspan Stent-Assisted Recanalization for Acute Itracranial Arterial (Saris)
- A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide
- A Phase I Window, Dose Escalating & Safety Trial of Metformin in Combination With Induction Chemotherapy in Relapsed....
- A Phase I, Open Label Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Oral Doses
- A Phase I, Open Label, Multi-Center Clinical Trial to Determine Antibody Concentrations of Veronate in Premature
- A Phase I, Study to Asscess the Pre-And Post-Dose Progesterone Level in Pregnant Women Receiving Prochieve....
- A Phase I/II Clinical Study of Oxi4503 in Aml and Mds
- A Phase I/II Dose-Escalation Study Evaluating the Combination of Neratinib and Cetuximab in Patients . . .
- A Phase I/II Study to Evaluate the Safety and Efficacy of Jvs-100 Administered By Retrograde Delivery to Cohorts....
- A Phase I/Iia Dose-Escalation Study Evaluating the Safety and Tolerability of Cxl-1020 and Specific Effects . . .
- A Phase Ib Study of the Safety and Tolerability of Ruxolitinib in Combination With Gemcitabine With or Without
- A Phase II 16 Week Double-Blind Placebo-Controlled Parallel-Group Multicenter Trial to Assess Effect on Glycaemic...
- A Phase II Clinical Trial of Four Cycles of Doxorubicin and Cyclophosphamide Followed By Weekly Paclitaxel Given........
- A Phase II Clinical Trial of Lenalidomide and Prednisone in Low and Imtermediate-1 Ipss Risk, Non-Del (5Q) Mds Patients